18 F‐Florzolotau Positron Emission Tomography Imaging of Tau Pathology in the Living Brains of Patients with Corticobasal Syndrome
Movement Disorders · 2023
DOI: 10.1002/mds.29338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2023. Verfasst von Feng-Tao Liu und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, and State Key Laboratory of Med…. Hauptthemen laut MEDLINE: Corticobasal Degeneration, Positron-Emission Tomography, Tauopathies. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Recent development in tau‐sensitive tracers has sparkled significant interest in tracking tauopathies using positron emission tomography (PET) biomarkers. However, the ability of 18 F‐florzolotau PET imaging to topographically characterize tau pathology in corticobasal syndrome (CBS) remains unclear. Further, the question as to whether disease‐level differences exist with other neurodegenerative tauopathies is still unanswered.
Objective
To analyze the topographical patterns of tau pathology in the living brains of patients with CBS using 18 F‐florzolotau PET imaging and to examine whether differences with other tauopathies exist.
Methods
18 F‐florzolotau PET imaging was performed in 20 consecutive patients with CBS, 20 cognitively healthy controls (HCs), 20 patients with Alzheimer's disease (AD), and 16 patients with progressive supranuclear palsy–Richardson's syndrome (PSP‐RS). Cerebrospinal fluid (CSF) levels of β‐amyloid biomarkers were quantified in all patients with CBS. 18 F‐florzolotau uptake was quantitatively assessed using standardized uptake value ratios.
Results
Of the 20 patients with CBS, 19 (95%) were negative for CSF biomarkers of amyloid pathology; of them, three had negative 18 F‐florzolotau PET findings. Compared with HCs, patients with CBS showed increased 18 F‐florzolotau signals in both cortical and subcortical regions. In addition, patients with CBS were characterized by higher tracer retentions in subcortical regions compared with those with AD and showed a trend toward higher signals in cortical areas compared with PSP‐RS. An asymmetric pattern of 18 F‐florzolotau uptake was associated with an asymmetry of motor severity in patients with CBS.
Conclusions
In vivo 18 F‐florzolotau PET imaging holds promise for distinguishing CBS in the spectrum of neurodegenerative tauopathies. © 2023 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, and State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Nuclear Medicine & PET Center, National Center for Neurological Disorders, and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
- Institute of Neurology, Fudan University, Shanghai, China.
- Department of Integrated Traditional and Western Medicine, Huashan Hospital, Fudan University, Shanghai, China.
- APRINOIA Therapeutics Co., Ltd, Suzhou, China.
- Department of Biostatistics, School of Public Health, Fudan University, Shanghai, China.
ORCID-Profile: Feng-Tao Liu, Jia-Ying Lu, Xin-Yi Li, Gen Li, Chuantao Zuo, Jian Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, F. T., Lu, J. Y., Li, X. Y., Jiao, F. Y., Chen, M. J., Yao, R. X., Liang, X. N., Ju, Z. Z., Ge, J. J., Li, G., Shen, B., Wu, P., Song, J., Li, J., Sun, Y. M., Wu, J. J., Yen, T. C., Luo, J. F., Zhao, Q. H., …, & Progressive Supranuclear Palsy Neuroimage Initiative (2023). 18 F‐Florzolotau Positron Emission Tomography Imaging of Tau Pathology in the Living Brains of Patients with Corticobasal Syndrome. Movement Disorders. https://doi.org/10.1002/mds.29338
Vancouver
Liu FT, Lu JY, Li XY, Jiao FY, Chen MJ, Yao RX, et al. 18 F‐Florzolotau Positron Emission Tomography Imaging of Tau Pathology in the Living Brains of Patients with Corticobasal Syndrome. Movement Disorders. 2023. doi:10.1002/mds.29338
BibTeX
@article{Liu2023,
author = {Liu, Feng-Tao and Lu, Jia-Ying and Li, Xin-Yi and Jiao, Fang-Yang and Chen, Ming-Jia and Yao, Rui-Xin and Liang, Xiao-Niu and Ju, Zi-Zhao and Ge, Jing-Jie and Li, Gen and Shen, Bo and Wu, Ping and Song, Jiong and Li, Ji and Sun, Yi-Min and Wu, Jian-Jun and Yen, Tzu-Chen and Luo, Jian-Feng and Zhao, Qian-Hua and Zuo, Chuantao and Wang, Jian and Progressive Supranuclear Palsy Neuroimage Initiative, Progressive Supranuclear Palsy Neuroimage Initiative},
title = {18 F‐Florzolotau Positron Emission Tomography Imaging of Tau Pathology in the Living Brains of Patients with Corticobasal Syndrome},
journal = {Movement Disorders},
year = {2023},
doi = {10.1002/mds.29338}
}
EUVIMED